Comparison of Effectiveness of the Mindfulness-Based Cognitive Therapy and the Metacognition Treatment on Anxiety, Depression and Stress Among Breast Cancer Patients
International Clinical Neuroscience Journal,
Vol. 5 No. 2 (2018),
19 June 2018
Background: The present study aimed to compare the effectiveness the metacognition treatment (MCT) and mindfulness-based cognitive therapy (MBCT) on anxiety, depression, and stress in the females with breast cancer.
Methods: The planning of this study is through a quasi-experimental method of pretest and posttest type with control group. The target society of the research included every cancer patient who admitted to Tehran hospitals for breast cancer. Through assigned randomly, 12 patients were selected for the MCT group and 12 patients for the MBCT group, and the other were assigned control group. The data collection tools included depression, anxiety and stress scale - 21 items (DASS-21) questionnaire. For statistical analysis, descriptive tests and repeated measures analysis of variance were performed.
Results: Data analysis with repeated multivariate measurements illustrated that there is a significant difference in the rate of depression, anxiety and stress, in three groups.
Conclusion: According to our results, MBCT was more effective compared to metacognitive therapy.
- Mindfulness-based cognitive therapy
- Metacognition therapy
- Breast cancer
How to Cite
Rahmani S, Talepasand S. The effect of group mindfulness - based stress reduction program and conscious yoga on the fatigue severity and global and specific life quality in women with breast cancer. Med J Islam Repub Iran. 2015;29:175.
Chen PY, Chang HC. The coping process of patients with cancer. Eur J Oncol Nurs. 2012;16(1):10-6. doi: 10.1016/j. ejon.2011.01.002.
Micheli A, Coebergh JW, Mugno E, Massimiliani E, Sant M, Oberaigner W, et al. European health systems and cancer care. Ann Oncol. 2003;14 Suppl 5:v41-60.
Hopko DR, Bell JL, Armento M, Robertson S, Mullane C, Wolf N, et al. Cognitive-behavior therapy for depressed cancer patients in a medical care setting. Behav Ther. 2008;39(2):126- 36. doi: 10.1016/j.beth.2007.05.007.
Teasdale JD, Segal ZV, Williams JM, Ridgeway VA, Soulsby JM, Lau MA. Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. J Consult Clin Psychol. 2000;68(4):615-23.
Daughters SB, Braun AR, Sargeant MN, Reynolds EK, Hopko DR, Blanco C, et al. Effectiveness of a brief behavioral treatment for inner-city illicit drug users with elevated depressive symptoms: the life enhancement treatment for substance use (LETS Act!). J Clin Psychiatry. 2008;69(1):122- 9.
Jacobson NS, Dobson KS, Truax PA, Addis ME, Koerner K, Gollan JK, et al. A component analysis of cognitive-behavioral treatment for depression. J Consult Clin Psychol. 1996;64(2):295-304.
Roelofs J, Huibers M, Peeters F, Arntz A, van Os J. Rumination and worrying as possible mediators in the relation between neuroticism and symptoms of depression and anxiety in clinically depressed individuals. Behav Res Ther. 2008;46(12):1283-9. doi: 10.1016/j.brat.2008.10.002.
Fisher PL, Wells A. Metacognitive therapy for obsessive-compulsive disorder: a case series. J Behav Ther Exp Psychiatry. 2008;39(2):117-32. doi: 10.1016/j.jbtep.2006.12.001.
Williams JM, Duggan DS, Crane C, Fennell MJ. Mindfulness-based cognitive therapy for prevention of recurrence of suicidal behavior. J Clin Psychol. 2006;62(2):201-10. doi: 10.1002/jclp.20223.
Wells A. Metacognitive therapy for anxiety and depression. New York: Guilford Press; 2015.
Osborn RL, Demoncada AC, Feuerstein M. Psychosocial interventions for depression, anxiety, and quality of life in cancer survivors: meta-analyses. Int J Psychiatry Med. 2006;36(1):13-34. doi: 10.2190/eufn-rv1k-y3tr-fk0l.
Kabat-Zinn J. Mindfulness-Based Interventions in Context: Past, Present, and Future. Clinical Psychology: Science and Practice. 2003;10(2):144-56. doi: 10.1093/clipsy.bpg016.
Kabat-Zinn J. Coming to our senses: Healing ourselves and the world through Mindfulness. New York: Hyperion; 2015.
Matousek RH, Dobkin PL, Pruessner J. Cortisol as a marker for improvement in mindfulness-based stress reduction. Complement Ther Clin Pract. 2010;16(1):13-9. doi: 10.1016/j. ctcp.2009.06.004.
Brantley J. Mindfulness-based cognitive therapy. In: Orsillo SM, Roemer L, eds. Acceptance and mindfulness-based approaches to anxiety: Conceptualization and treatment. New York: Springer; 2015:131-45.
Baer R. Mindfulness-based treatment approaches: Clinician’s guide to evidence base and applications. San Diego: Elsevier; 2012.
Speca M, Carlson LE, Goodey E, Angen M. A randomized, wait-list controlled clinical trial: the effect of a mindfulness meditation-based stress reduction program on mood and symptoms of stress in cancer outpatients. Psychosom Med. 2000;62(5):613-22.
Carlson LE, Speca M, Patel KD, Goodey E. Mindfulness-based stress reduction in relation to quality of life, mood, symptoms of stress, and immune parameters in breast and prostate cancer outpatients. Psychosom Med. 2003;65(4):571-81.
Carlson L, Specs M. Mindfulness-Based Cancer Recovery: A Step-by-Step MBSR Approach to Help You Cope with Treatment and Reclaim Your Life. Oakland, CA: New Harbinger; 2011:17-31.
Zeichner RL, Kibler JL, Zeichner SB. Relationship between Mindfulness-based cognitive therapy and Immune Function in Cancer and HIV/AIDS. Cancer Clin Oncol. 2013;2(1):62- 72.
Hasanvandi S, Valizadeh M, Mehrabizadeh M. Effect of group metacognitive therapy on depression symptom and rumination. Journal of Fundamentals of Mental Health. 2013;15(57):432-42.
Wells A, Welford M, Fraser J, King P, Mendel E, Wisely J, et al. Chronic PTSD Treated With Metacognitive Therapy: An Open Trial. Cogn Behav Pract. 2008;15(1):85-92. doi: 10.1016/j. cbpra.2006.11.005.
Wells A, Sembi S. Metacognitive therapy for PTSD: a preliminary investigation of a new brief treatment. J Behav Ther Exp Psychiatry. 2004;35(4):307-18. doi: 10.1016/j. jbtep.2004.07.001.
Wells A, Papageorgiou C. Brief cognitive therapy for social phobia: a case series. Behav Res Ther. 2001;39(6):713-20.
Chaskalon M. The mindful workplace: developing resilient individuals and resonant organizations with MBSR. Wiley- Blackwell; 2011:230-2.
Lovibond PF, Lovibond SH. The structure of negative emotional states: comparison of the Depression Anxiety Stress Scales (DASS) with the Beck Depression and Anxiety Inventories. Behav Res Ther. 1995;33(3):335-43.
Antony MM, Bieling PJ, Cox BJ, Enns MW, Swinton RP. Psychometric properties of the 42-item and 21-item versions of the Depression Anxiety Stress Scales in clinical groups and a community sample. Psychol Assess.1998;10(2):176-81. doi: 10.1037/1040-35126.96.36.199.
Samani S, Jokar B. A study on the reliability and validity of the short form of the depression anxiety stress scale (DASS- 21). Journal of Social Sciences and Humanities of Shiraz University. 2007;26(3):65-75. (Persian).
Rahmani S, Talepasand S, Ghanbary-Motlagh A. Comparison of effectiveness of the metacognition treatment and the mindfulness-based stress reduction treatment on global and specific life quality of women with breast cancer. Iran J Cancer Prev. 2014;7(4):184-96.
Talepasand S, Pooragha F, Kazemi M. Resiliency and quality of life in patients with cancer: moderating role of duration of awareness of cancer. Iran J Cancer Prev. 2013;6(4):222-6.
Meeker MA, Finnell D, Othman AK. Family caregivers and cancer pain management: a review. J Fam Nurs. 2011;17(1):29-60. doi: 10.1177/1074840710396091.
Lengacher CA, Johnson-Mallard V, Barta M, Fitzgerald S, Moscoso MS, Post-White J, et al. Feasibility of a mindfulness-based stress reduction program for early-stage breast cancer survivors. J Holist Nurs. 2011;29(2):107-17. doi: 10.1177/0898010110385938.
Carmody J, Baer RA. Relationships between mindfulness practice and levels of mindfulness, medical and psychological symptoms and well-being in a mindfulness-based stress reduction program. J Behav Med. 2008;31(1):23-33. doi: 10.1007/s10865-007-9130-7.
- Abstract Viewed: 586 times
- PDF Downloaded: 623 times